Loading
A Basel medical oncologist who chairs the board of Switzerland's national academic cancer trials group.
Viviane Hess is listed as President (Präsidentin) of the board of the Swiss Cancer Institute, the national academic cancer trials organisation known until July 2025 as SAKK. Her paper affiliations are the Department of Medical Oncology, University Hospital Basel, and the Faculty of Medicine, University of Basel. She is a co-author of the long-term follow-up of the SAKK 75/08 phase 3 trial in oesophageal cancer, which analysed recurrence in 103 of the trial's 300 patients and found that time to recurrence, the number of recurrence sites and the use of systemic or second curative local therapy correlated with survival, and of psycho-oncology studies for cancer survivors at Basel.
| Title | Journal | Year |
|---|---|---|
| Patterns of care for relapsed oesophageal cancer after initial curative trimodality therapy: Long-term follow-up of the SAKK 75/08 trial Panje C, Hayoz S, Eisterer W, Hess V, et al. PMID 36368252. | European Journal of Cancer | 2022 |
| Group-based body psychotherapy improves appreciation of body awareness in post-treatment cancer patients: A non-randomized clinical trial Grossert A, Meffert C, Hess V, et al. PMID 37089722. | Frontiers in Psychology | 2023 |
Shares Swiss Cancer Institute (formerly SAKK), University Hospital Basel / Tumour Centre.
Shares Swiss Cancer Institute (formerly SAKK), University Hospital Basel / Tumour Centre.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/